MS
Therapeutic Areas
Regeneration Biomedical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Autologous Wnt-activated ADSC Therapy | Alzheimer's Disease | Phase 1 |
Leadership Team at Regeneration Biomedical
BM
Bill Miller
CEO
CD
Christopher Duma, MD, FACS
President and Founder
BL
Bob Lynn
COO/Research Director
HS
Hans S. Keirstead, PhD
Scientific Advisor
GN
Gabriel Nistor, MD
Scientific Advisor
YJ
Yasir Jassam, MBChB MRCP(UK) FRCP(Glasg) FRCP FAAN
Scientific Advisor